RACMA has developed a dedicated, central source of information to help Medical Leaders and decision makers navigate through the current challenge on Australasia’s health system.
This section will be updated when new information becomes available.
RACMA is encouraging all members and non-members to email any queries or useful resources to the College at email@example.com.
- Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant – New England Journal of Medicine (NEJM) Jamie Lopez Bernal, Nick Andrews, Charlotte Gower, Eileen Gallagher, Ruth Simmons, Simon Thelwall, Julia Stowe, Elise Tessier, Natalie Groves, Gavin Dabrera, Richard Myers, Colin N J Campbell, Gayatri Amirthalingam, Matt Edmunds, Maria Zambon, Kevin E Brown, Susan Hopkins, Meera Chand, Mary Ramsay
- Antibodies, Immunity, and COVID-19 – The Journal of the American Medical Association (JAMA) Internal Medicine Brad Spellberg, MD; Travis B. Nielsen, PhD; Arturo Casadevall, MD, PhD
- Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020 – The Journal of the American Medical Association (JAMA) Internal Medicine Kristina L. Bajema, MD, MSc; Ryan E. Wiegand, MS; Kendra Cuffe, MPH; Sadhna V. Patel, MPH; Ronaldo Iachan, PhD; Travis Lim, DrPH; Adam Lee, MS; Davia Moyse, MA; Fiona P. Havers, MD, MHS; Lee Harding, MS; Alicia M. Fry, MD, MPH; Aron J. Hall, DVM, MSPH; Kelly Martin, MPH; Marjorie Biel, MPH; Yangyang Deng, MS; William A. Meyer III, PhD; Mohit Mathur,MD, PhD; Tonja Kyle, MS; Adi V. Gundlapalli, MD, PhD; Natalie J. Thornburg, PhD; Lyle R. Petersen, MD, MPH; Chris Edens, PhD